Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Oncotarget|November 19, 2013
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axisDaniela Lötsch, Elisabeth Steiner, Klaus Holzmann, et al.
Oncotarget|April 2, 2016
Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cellsKushtrim Kryeziu, Christine Pirker, Bernhard Englinger, et al.
Inorganic Chemistry Frontiers|April 7, 2025
Albumin-targeted oxaliplatin(iv) prodrugs bearing STING agonistsMartijn Dijkstra, Michael Gutmann, Mathias Gradl, et al.
Cancer Letters|July 19, 2017
Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasisBeatrix Schoenhacker-Alte, Thomas Mohr, Christine Pirker, et al.
Cancer Research|April 6, 2006
Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERTAndreas Brachner, Soleman Sasgary, Christine Pirker, et al.
Communications Chemistry|January 25, 2023
Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolismAlessio Terenzi, Mery La Franca, Sushilla van Schoonhoven, et al.
Experimental Hematology & Oncology|August 23, 2025
The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulationBianca Stiller, Alessia Stefanelli, Hemma Schueffl, et al.
Molecular Cancer Therapeutics|January 24, 2015
Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic conceptsVerena Paulitschke, Walter Berger, Philipp Paulitschke, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 9, 2017
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancerBernhard Englinger, Sebastian Kallus, Julia Senkiv, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2023
Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesotheliomaPaul Stockhammer, Hannah Baumeister, Till Ploenes, et al.
Pageof 9